Fragment Size Ratio (FSR)
Command: krewlyzer fsr
Purpose
Computes ratios of fragment size classes per genomic window. Unlike FSC, this metric is self-normalizing (ratio) and focuses on the proportion of fragment sizes, which is a powerful biomarker for tumor fraction estimation.
Biological Context
The ratio of short to long fragments is a key indicator of tumor burden in cfDNA ("fragmentomics"). See DELFI method for details.
- Short Fragments (65-149bp): Tumor DNA is typically shorter (~145bp) than healthy DNA (~166bp).
- Ultra-short Fragments (65-100bp): Associated with transcription factor binding sites and open chromatin.
- Long Fragments (261-399bp): Often di-nucleosomes, representing stable, healthy chromatin (Leukocytes).
Key Biomarkers: - Short/Long Ratio: The primary metric. Higher ratio = higher probability of tumor DNA. - Ultra-short Ratio: Indicates active gene regulation/transcription factor binding. - Nucleosome Footprints: The 10bp precision of the ranges (150bp vs 167bp) helps separate mono-nucleosomes.
Usage
Options
--bin-input, -b: Bin file (default:data/ChormosomeBins/hg19_window_100kb.bed)--windows, -w: Window size (default: 100000)--continue-n, -c: Consecutive window number (default: 50)--gc-correct/--no-gc-correct: Apply GC bias correction using LOESS (default: True)--verbose, -v: Enable verbose logging--threads, -p: Number of threads.
Output Format
Output: {sample}.FSR.tsv
| Column | Description | Biological Relevance |
|---|---|---|
region |
Genomic region | |
ultra_short_count |
Count 65-100bp | TF footprints |
short_count |
Count 65-149bp | Tumor enriched |
inter_count |
Count 151-259bp | Mono-nucleosome |
long_count |
Count 261-399bp | Healthy / Di-nucleosome |
total_count |
Count 65-399bp | Total fragments |
short_ratio |
Short / Total | Tumor fraction proxy |
inter_ratio |
Intermediate / Total | |
long_ratio |
Long / Total | Healthy fraction proxy |
short_long_ratio |
Short / Long | Primary Cancer Biomarker |
ultra_short_ratio |
Ultra-short / Total | TF activity indicator |
Clinical Interpretation
Healthy vs Cancer
| Metric | Healthy Plasma | Cancer (ctDNA present) |
|---|---|---|
| Modal fragment size | ~166bp | Left-shifted (~145bp) |
short_long_ratio |
Low (baseline) | Elevated |
| Genome-wide ratio variability | Minimal | Increased aberrations |
Interpretation Guide
- High
short_long_ratio: Indicates higher tumor fraction (ctDNA) or open chromatin. - High
ultra_short_ratio: Indicates regions of high transcription factor activity. - High
long_ratio: Indicates stable, nucleosomal DNA (usually healthy background).
Clinical Utility
- Tumor fraction proxy: Compare
short_long_ratioto healthy baseline - Treatment monitoring: Track ratio changes over time
- Performance: DELFI achieves 57-99% sensitivity at 98% specificity
Reference: See Citation & Scientific Background for detailed paper summary.